#842: The Story Behind EpiPen, The Rise of Food Allergies, and What Doctors Got Wrong

What It Covers

The EpiPen's rise to blockbuster status parallels a food allergy epidemic caused by misguided medical guidance. Official recommendations to avoid allergens in infancy actually triggered widespread allergies, creating massive demand for emergency epinephrine injections.

Key Questions Answered

• •Medical reversal: The American Academy of Pediatrics' 2000 guidance to delay introducing peanuts until age three created a feedback loop—avoidance increased sensitization, driving allergy rates from one percent in the 1970s to five percent by 1995, then ten percent by 2024.
• •LEAP study breakthrough: Gideon Lack's randomized trial exposed 640 infants to peanuts from four months old, reducing allergy rates to 1.9 percent versus 14 percent in the avoidance group—an 86 percent reduction comparable to successful vaccines, reversing decades of wrong guidance.
• •Price exploitation mechanics: Mylan tripled EpiPen prices from $109 to $600 per two-pack between 2007-2016 by mandating two-packs instead of singles, lobbying for school requirements, providing free training only on EpiPens, and offering discounted devices to schools that agreed not to purchase competitors.
• •Hygiene hypothesis impact: Excessive cleanliness and daily infant bathing with consumer products removes natural skin oils that protect immune development. Reduced early exposure to diverse proteins makes immune systems mistake benign food proteins for poisons, triggering allergic reactions upon first real exposure.